Colesevelam
ArticlesMedicine Compliance Aid StabilityLactation Safety Information · Published , updated
441851004
Articles
3 November 2020
Shortage of Bile acid sequestrants: colestyramine powder for oral suspension 4g (Questran), and colestipol (Colestid)
Bristol-Myers Squibb divested the Questran range to Cheplapharm at the end of July 2019. This affected the availability of several bile acid sequestrants. The current… Colesevelam Colestipol Colestyramine Supply
25 September 2020
Safety in Lactation: Drugs for hyperlipidaemias
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. There is no evidence for the… Alirocumab Atorvastatin Bezafibrate Cardiovascular system disorders Ciprofibrate Colesevelam Colestipol Colestyramine Eicosapentaenoic acid + Docosahexaenoic acid Evolocumab Ezetimibe Fenofibrate Fluvastatin Gemfibrozil Obstetrics and gynaecology Paediatrics and neonates Pravastatin Rosuvastatin Safety in Breastfeeding SimvastatinMedicine Compliance Aid Stability
CholestagelSanofi
Sanofi
Cholestagel
Tablets f/c 625mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
9 November 2015
Lactation Safety Information
-
No published evidence of safety
Not absorbed from the mother’s GI tract
Theoretical effects of colestryramine on maternal cholesterol levels and availability of fat soluble vitamins (A, D, E, K) from the mother have not been shown to present a clinical risk to a breastfed infant
18 March 2017